23 patents
Page 2 of 2
Utility
PH20 Polypeptide Variants, Formulations and Uses Thereof
12 Aug 20
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided.
Ge WEI, H. Michael Shepard, Qiping Zhao, Robert James Connor
Filed: 18 Mar 20
Utility
Methods of Selecting Subjects for Combination Cancer Therapy with a Polymer-conjugated Soluble PH20
20 Nov 19
Provided herein are methods of selecting subjects having cancer for combination therapy that includes administering an anti-hyaluronan agent, such as a polymer-conjugated hyaluronan-degrading enzyme.
Song Wang, Darin M. Taverna, Carl Di Casoli, Nicholas Willumsen, Morten Karsdal, Thomas Mueller
Filed: 14 May 19
Utility
Modified Hyaluronidases and Uses In Treating Hyaluronan-associated Diseases and Conditions
6 Nov 19
Provided are combinations, compositions and kits containing a hyaluronan degrading enzyme, such as a soluble hyaluronidase, for treatment of hyaluronan-associated conditions, diseases and disorders.
Gregory I. Frost, Ping Jiang, Curtis B. Thompson
Filed: 20 May 19